Placental OPRM1 DNA methylation and associations with neonatal opioid withdrawal syndrome, a pilot study

AIMS: Epigenetic variation of DNA methylation of the mu-opioid receptor gene (OPRM1) has been identified in the blood and saliva of individuals with opioid use disorder (OUD) and infants with neonatal opioid withdrawal syndrome (NOWS). It is unknown whether epigenetic variation in OPRM1 exists withi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wachman, Elisha M., Wang, Alice, Isley, Breanna C., Boateng, Jeffery, Beierle, Jacob A., Hansbury, Aaron, Shrestha, Hira, Bryant, Camron, Zhang, Huiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985727/
https://www.ncbi.nlm.nih.gov/pubmed/33763662
http://dx.doi.org/10.37349/emed.2020.00009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985727/
https://www.ncbi.nlm.nih.gov/pubmed/33763662
http://dx.doi.org/10.37349/emed.2020.00009

Ejemplares similares